7.341 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy, Fall 2009
Where do new drugs and treatments come from? This class will take you from the test tubes and mice of the laboratory to the treatment of patients with deadly blood disorders. Students will learn how to think as a scientist through discussion of primary research papers describing the discoveries of s...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Learning Object |
| Language: | en-US |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/1721.1/148359 |
| _version_ | 1826201948432367616 |
|---|---|
| author | Flygare, Johan Wong, Bill |
| author2 | Massachusetts Institute of Technology. Department of Biology |
| author_facet | Massachusetts Institute of Technology. Department of Biology Flygare, Johan Wong, Bill |
| author_sort | Flygare, Johan |
| collection | MIT |
| description | Where do new drugs and treatments come from? This class will take you from the test tubes and mice of the laboratory to the treatment of patients with deadly blood disorders. Students will learn how to think as a scientist through discussion of primary research papers describing the discoveries of several novel treatments. Topics such as gene therapy, the potential of drugs based on RNA interference and the reprogramming of somatic cells into stem cells for regenerative medicine will be discussed. This course is one of many Advanced Undergraduate Seminars offered by the Biology Department at MIT. These seminars are tailored for students with an interest in using primary research literature to discuss and learn about current biological research in a highly interactive setting. Many instructors of the Advanced Undergraduate Seminars are postdoctoral scientists with a strong interest in teaching. |
| first_indexed | 2024-09-23T11:59:51Z |
| format | Learning Object |
| id | mit-1721.1/148359 |
| institution | Massachusetts Institute of Technology |
| language | en-US |
| last_indexed | 2025-03-10T10:18:14Z |
| publishDate | 2023 |
| record_format | dspace |
| spelling | mit-1721.1/1483592025-02-26T21:25:45Z 7.341 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy, Fall 2009 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy Flygare, Johan Wong, Bill Massachusetts Institute of Technology. Department of Biology molecularly targeted therapy blood disorders chronic myelogenous leukemia CML Gleevec chromosomal translocation stem cells blood cells hematopoiesis hematopoieteic stem cell genetic disorder Leukemia 511010 Cytogenetics/Genetics/Clinical Genetics Technology/Technologist Where do new drugs and treatments come from? This class will take you from the test tubes and mice of the laboratory to the treatment of patients with deadly blood disorders. Students will learn how to think as a scientist through discussion of primary research papers describing the discoveries of several novel treatments. Topics such as gene therapy, the potential of drugs based on RNA interference and the reprogramming of somatic cells into stem cells for regenerative medicine will be discussed. This course is one of many Advanced Undergraduate Seminars offered by the Biology Department at MIT. These seminars are tailored for students with an interest in using primary research literature to discuss and learn about current biological research in a highly interactive setting. Many instructors of the Advanced Undergraduate Seminars are postdoctoral scientists with a strong interest in teaching. 2023-03-06T17:31:06Z 2023-03-06T17:31:06Z 2009-12 2023-03-06T17:31:12Z Learning Object 7.341-Fall2009 7.341 IMSCP-MD5-e7749bc6b8079c335015707858b81d06 https://hdl.handle.net/1721.1/148359 en-US This site (c) Massachusetts Institute of Technology 2023. Content within individual courses is (c) by the individual authors unless otherwise noted. The Massachusetts Institute of Technology is providing this Work (as defined below) under the terms of this Creative Commons public license ("CCPL" or "license") unless otherwise noted. The Work is protected by copyright and/or other applicable law. Any use of the work other than as authorized under this license is prohibited. By exercising any of the rights to the Work provided here, You (as defined below) accept and agree to be bound by the terms of this license. The Licensor, the Massachusetts Institute of Technology, grants You the rights contained here in consideration of Your acceptance of such terms and conditions. Attribution-NonCommercial-ShareAlike 3.0 Unported http://creativecommons.org/licenses/by-nc-sa/3.0/ text/plain text/html image/jpeg image/jpeg text/html text/html text/html text/html text/html application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream application/octet-stream text/css text/css text/css text/css text/css text/css text/css text/css text/css text/css text/css text/css text/css text/css text/css text/css text/html image/png image/png image/png image/png image/gif image/png image/png image/png image/jpeg image/gif image/png image/png image/png image/gif image/png image/png image/png image/png image/png image/png image/gif image/png image/png image/gif image/gif image/png image/png image/png image/png image/png image/png image/png image/png image/png image/gif image/jpeg image/gif image/png image/jpeg image/png image/png image/png image/png image/png image/png image/png image/png image/png image/gif image/png image/png image/jpeg image/gif image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/gif image/gif image/gif image/gif image/gif image/gif image/gif image/gif image/gif image/gif image/gif image/gif image/png image/gif application/octet-stream image/gif image/gif image/png image/gif image/gif image/gif image/png image/png application/octet-stream image/gif image/gif image/gif image/gif image/png image/gif image/gif application/octet-stream image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png image/png application/rdf+xml; charset=utf-8 text/html image/png image/png image/jpeg image/png image/png image/png image/png image/png text/html text/html Fall 2009 |
| spellingShingle | molecularly targeted therapy blood disorders chronic myelogenous leukemia CML Gleevec chromosomal translocation stem cells blood cells hematopoiesis hematopoieteic stem cell genetic disorder Leukemia 511010 Cytogenetics/Genetics/Clinical Genetics Technology/Technologist Flygare, Johan Wong, Bill 7.341 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy, Fall 2009 |
| title | 7.341 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy, Fall 2009 |
| title_full | 7.341 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy, Fall 2009 |
| title_fullStr | 7.341 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy, Fall 2009 |
| title_full_unstemmed | 7.341 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy, Fall 2009 |
| title_short | 7.341 Bench to Bedside: Molecularly Targeted Therapies in Blood Disorders and Malignancy, Fall 2009 |
| title_sort | 7 341 bench to bedside molecularly targeted therapies in blood disorders and malignancy fall 2009 |
| topic | molecularly targeted therapy blood disorders chronic myelogenous leukemia CML Gleevec chromosomal translocation stem cells blood cells hematopoiesis hematopoieteic stem cell genetic disorder Leukemia 511010 Cytogenetics/Genetics/Clinical Genetics Technology/Technologist |
| url | https://hdl.handle.net/1721.1/148359 |
| work_keys_str_mv | AT flygarejohan 7341benchtobedsidemolecularlytargetedtherapiesinblooddisordersandmalignancyfall2009 AT wongbill 7341benchtobedsidemolecularlytargetedtherapiesinblooddisordersandmalignancyfall2009 AT flygarejohan benchtobedsidemolecularlytargetedtherapiesinblooddisordersandmalignancy AT wongbill benchtobedsidemolecularlytargetedtherapiesinblooddisordersandmalignancy |